Right‐sided non‐recurrent laryngeal nerve without any vascular anomaly: an anatomical trap
暂无分享,去创建一个
J. Saiz | S. Ferrari | A. Lombardi | I. Cortella | M. A. Businaro | A. Bertomoro | Irene Di Pasquale | F. Fabris | M. Martín-Acebes | E. Escribano-Romero | A. Blázquez | F. Hayati | B. T. Yeap | T. Merino-Ramos | R. Guad | Á. Vázquez-Calvo | N. J. de Oya | T. Thein | M. Z. Soe
[1] M. Scully,et al. Rituximab prophylaxis to prevent thrombotic thrombocytopenic purpura relapse: outcome and evaluation of dosing regimens. , 2017, Blood advances.
[2] D. Brody,et al. Clinical and imaging assessment of acute combat mild traumatic brain injury in Afghanistan , 2015, Neurology.
[3] P. Eggleton. Hypersensitivity: Immune Complex Mediated (Type III) , 2013 .
[4] G. Ling,et al. Neurology and the military: Five new things. , 2013, Neurology. Clinical practice.
[5] A. Payne,et al. Inhibitory human antichimeric antibodies to rituximab in a patient with pemphigus. , 2012, The Journal of allergy and clinical immunology.
[6] H. Gopal,et al. Serum sickness and severe angioedema following rituximab therapy in RA , 2012, International journal of rheumatic diseases.
[7] M. Raichle,et al. Detection of blast-related traumatic brain injury in U.S. military personnel. , 2011, The New England journal of medicine.
[8] J. Monroe,et al. B‐cell targeted therapies in human autoimmune diseases: an updated perspective , 2010, Immunological reviews.
[9] H. Goto,et al. Serum sickness with an elevated level of human anti-chimeric antibody following treatment with rituximab in a child with chronic immune thrombocytopenic purpura , 2009, International journal of hematology.
[10] S. Helfgott,et al. Serum sickness following treatment with rituximab. , 2007, The Journal of rheumatology.
[11] J. Cavenagh,et al. Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS‐13 , 2007, British journal of haematology.
[12] X. Mariette,et al. Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren’s syndrome , 2006, Annals of the rheumatic diseases.
[13] K. Saito,et al. Extremely high titer of anti-human chimeric antibody following re-treatment with rituximab in a patient with active systemic lupus erythematosus. , 2005, Rheumatology.
[14] Robert Jackson. Serum Sickness , 2000, Journal of cutaneous medicine and surgery.
[15] Sharon Willis,et al. Uniformed Services University of the Health Sciences. , 2003, Academic medicine : journal of the Association of American Medical Colleges.